Skip to main content

. 1963 Jan;157(1):39–47. doi: 10.1097/00000658-196301000-00004

Prevention of Irreversible Hemorrhagic Shock with Fibrinolysin ^{^*}

Robert M Hardaway, Dennis C Drake

PMCID: PMC1466408 PMID: 13952730

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

HARDAWAY R. M., BRUNE W. H., GEEVER E. F., BURNS J. W., MOCK H. P. Studies on the role of intravascular coagulation in irreversible hemorrhagic shock. Ann Surg. 1962 Feb;155:241–250. doi: 10.1097/00000658-196200000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
Jaques L. B., Waters E. T. The identity and origin of the anticoagulant of anaphylactic shock in the dog. J Physiol. 1941 Jun 30;99(4):454–466. doi: 10.1113/jphysiol.1941.sp003915. [DOI] [PMC free article] [PubMed] [Google Scholar]
LASCH H. G., MECHELKE K., NUSSER E., DAOUD F. [The effect of fibrinolysis on the courses of hemorrhagic shock]. Klin Wochenschr. 1961 Nov 1;39:1137–1141. doi: 10.1007/BF01481830. [DOI] [PubMed] [Google Scholar]
OWREN P. A., AAS K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest. 1951;3(3):201–208. doi: 10.3109/00365515109060600. [DOI] [PubMed] [Google Scholar]
REID D. E., WEINER A. E., ROBY C. C. Intravascular clotting and afibrinogenemia, the presumptive lethal factors in the syndrome of amniotic fluid embolism. Am J Obstet Gynecol. 1953 Sep;66(3):465–474. doi: 10.1016/0002-9378(53)90065-9. [DOI] [PubMed] [Google Scholar]
VON KAULLA K. N., SCHULTZ R. L. Methods for the evaluation of human fibrinolysis; studies with two combined technics. Am J Clin Pathol. 1958 Feb;29(2):104–112. doi: 10.1093/ajcp/29.2.104. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES